Biotime signs stem cell deal
Contra Costa Times Wed, 25 Jun 2008 10:16 AM PDT
Alameda-based Biotime has entered into a production agreement with International Stem Cell Corp. to create standardized human and animal cell lines. The products will be sold for research pruposes, such as drug discovery and drug development uses, Biotime said Wednesday in a filing. |
International stem-cell collaborations launched
Nature Wed, 25 Jun 2008 10:15 AM PDT
California's stem-cell institute has penned two international research agreements, including a pact with Canada that will bring in at least US$100 million for cancer-related studies. |
Stem cell research from an ethical point of view
PhysOrg Wed, 25 Jun 2008 10:08 AM PDT
Stem cell research and the potential use of human embryonic stem cells in clinical therapy is a controversial issue which splits both scientific and public opinion. The current conflict over embryonic stem cells throughout the world deals particularly with the ethical implications of this promising, but delicate subject and the scientific manipulation of human life in its early stages of ... |
Stem cell investments may become state tax credits
Courier-Post Wed, 25 Jun 2008 9:40 AM PDT
TRENTON - One state lawmaker thinks he's found a way to fund stem-cell research in New Jersey without facing the ethical and financial protests that blocked a measure to borrow $450 million for the research last fall. |
BioTime inks deal to create hundreds of stem cell lines
San Francisco Business Times Wed, 25 Jun 2008 10:47 AM PDT
BioTime and its Embryone Sciences subsidiary will help to create "hundreds of new standardized human and animal stem cell lines" for treatment research in a deal with International Stem Cell Corp. |
Stem cell treatment in clinical trial at Texas Heart Institute at St. Luke's
Pearland Journal Wed, 25 Jun 2008 9:34 AM PDT
Physician scientists at the Texas Heart Institute (THI) at St. Luke's Episcopal Hospital announced they have begun the world's first clinical trial to treat heart attack patients with a special type of stem cell to promote better healing and to prevent congestive heart failure, which many patients develop following a heart attack.... |
International Stem Cell Corporation Signs Agreement with BioTime, Inc., and Embryome Sciences, Inc., to Provide Unique ...
Centre Daily Times Wed, 25 Jun 2008 7:54 AM PDT
International Stem Cell Corporation (OTCBB:ISCO), through its wholly owned subsidiary Lifeline Cell Technology (Lifeline), has signed a manufacturing and distribution agreement with BioTime, Inc., (OTCBB:BTIM) (Alameda, CA) and BioTime's wholly owned subsidiary Embryome Sciences, Inc., to jointly produce and distribute hundreds of new standardized human and animal stem cell lines, along with ... |
Mesoblast Limited (ASX:MSB) - Strong Progress Continues With Adult Stem Cell Therapy in Several Applications
ABN Newswire via Yahoo!7 Finance Wed, 25 Jun 2008 0:06 AM PDT
Melbourne, Australia, June 25, 2008 - (ABN Newswire) - According to the June edition of Bioshares, Mesoblast Limited (ASX:MSB)(USOTC:MBLTY)(PINK:MEOBF) has made exceptionally good progress with its adult stem cell therapy in several applications. "The company has a well-constructed business plan that is positioning the company to deliver on multiple licensing opportunities. |
MP Clement meets Schwarzenegger to sign stem cell deal
Parry Sound North Star Wed, 25 Jun 2008 9:08 AM PDT
Last week, federal Minister of Health and Parry Sound Muskoka MP Tony Clement signed an agreement with California Governor Arnold Schwarzenegger that will see $200 million dedicated to cancer stem cell research over the next three years. |
International Stem Cell Corporation Signs Agreement with BioTime, Inc., and Embryome Sciences, Inc., to Provide Unique ...
Business Wire via Yahoo! Finance Wed, 25 Jun 2008 6:30 AM PDT
OCEANSIDE, Calif.----International Stem Cell Corporation , through its wholly owned subsidiary Lifeline Cell Technology , has signed a manufacturing and distribution agreement with BioTime, Inc., and BioTime's wholly owned subsidiary Embryome Sciences, Inc., to jointly produce and distribute hundreds of new standardized human and animal stem cell lines, along with corresponding data and reagents. |
| |
|
